MedPath

A Study of Adipose Tissue in Adaptive Responses to Exercise

Not Applicable
Recruiting
Conditions
Healthy
Obesity
Interventions
Procedure: Adipose Tissue Biopsy
Behavioral: Exercise
Registration Number
NCT06053125
Lead Sponsor
Mayo Clinic
Brief Summary

The purpose of this research is to determine how exercise affects fat (adipose) tissue and how changes to adipose tissue that occur during and after exercise might improve health in aging and obesity.

Detailed Description

Adipose tissue has important endocrine functions that influence metabolic health. Early evidence shows that adipose adapts to physiological stress, including exercise. The objective here is to determine how exercise-induced alterations in adipose tissue cellular composition and endocrine signaling may contribute to the beneficial adaptations to exercise in aging and obesity.

Immune cell populations and inflammatory signatures will be assessed in subcutaneous abdominal adipose tissue biopsies collected from obese and normal weight young and older adults before, immediately after, and 3 hours after a 30-min bout of cycling exercise at 70% of maximal oxygen consumption (VO2max). Mass spectrometry, Olink targeted inflammation assays, and RNA sequencing will be used for full proteomic and transcriptomic characterization of the adipose tissue secretome (the proteins and molecules secreted from the adipose tissue) and the cargo of extracellular vesicles isolated from plasma and media collected from cultured human adipose tissue explants generated from each time point.

Overall, the primary hypothesis of the proposed work is that a single bout of exercise triggers transient changes in adipose tissue paracrine/endocrine signals and immune cellular composition. The investigators propose that these responses contribute to the beneficial effects of exercise locally and in distal tissues and that the cumulative effects of acute changes in adipose tissue likely contribute to the positive alterations in adipose tissue associated with exercise training.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Adults between the ages of 18-35 OR 65-85.
  • BMI 18.5 kg/m2 - 40 kg/m2
  • Weight stable (≥ 3 months)
  • Generally healthy
Exclusion Criteria
  • Participation in ≥ 30 minutes of structured physical activity ≥ 2 days per week.
  • Smoking/tobacco use.
  • Alcohol/substance abuse.
  • Pregnancy and breastfeeding.
  • Anemia.
  • Abnormal renal function.
  • Blood clotting disorders.
  • Coronary artery disease.
  • Uncontrolled thyroid disease.
  • Liver disease.
  • Use of medications known to influence the main outcomes of the study.
  • Orthopedic problems that may be aggravated by exercise.
  • Chronic disease at the discretion of the investigators.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Older adults with obesityExerciseParticipants with a body mass index (BMI) between 30 and 40 and aged 65-85 years will have an adipose tissue biopsy taken from the abdomen before and after exercise.
Young adults with obesityExerciseParticipants with a BMI between 30 and 40 and aged 18-35 years will have an adipose tissue biopsy taken from the abdomen before and after exercise.
Young adults without obesityAdipose Tissue BiopsyParticipants with a BMI between 18.5 and 28 and aged 18-35 years will have an adipose tissue biopsy taken from the abdomen before and after exercise.
Older adults with obesityAdipose Tissue BiopsyParticipants with a body mass index (BMI) between 30 and 40 and aged 65-85 years will have an adipose tissue biopsy taken from the abdomen before and after exercise.
Young adults without obesityExerciseParticipants with a BMI between 18.5 and 28 and aged 18-35 years will have an adipose tissue biopsy taken from the abdomen before and after exercise.
Older adults without obesityExerciseParticipants with a BMI between 18.5 and 28 and aged 65-85 years will have an adipose tissue biopsy taken from the abdomen before and after exercise.
Young adults with obesityAdipose Tissue BiopsyParticipants with a BMI between 30 and 40 and aged 18-35 years will have an adipose tissue biopsy taken from the abdomen before and after exercise.
Older adults without obesityAdipose Tissue BiopsyParticipants with a BMI between 18.5 and 28 and aged 65-85 years will have an adipose tissue biopsy taken from the abdomen before and after exercise.
Primary Outcome Measures
NameTimeMethod
Adipose tissue gene expression of interleukin (IL)-8 measured by PCR.Pre-exercise, immediately post-exercise, and 3 hours after exercise

Gene expression of the inflammatory cytokine IL-8 will be assessed in adipose tissue samples using real-time (RT)-PCR.

Adipose tissue macrophage populationsPre-exercise, immediately post-exercise, and 3 hours after exercise

Numbers of macrophages in the adipose tissue will be assessed by immunohistochemistry.

Inflammatory proteins secreted from adipose tissue measured using the Olink Target Inflammation Panel (includes 96 inflammation-associated proteins)Pre-exercise, immediately post-exercise, and 3 hours after exercise

The concentrations of 96 different inflammatory proteins (including various cytokines and adipokines) will be measured using the targeted inflammation Olink proximity extension assay panel in media obtained from cultured adipose tissue explants. Adipose tissue samples will be cultured for 3 hours, and the culture media will be removed for the assessment of 96 different secreted inflammatory proteins. The Olink assay measures all 96 proteins in a single assay and all are reported as normalized protein expression values.

Adipose tissue gene expression of cluster of differentiation 163 (CD163) measured by PCR.Pre-exercise, immediately post-exercise, and 3 hours after exercise

Gene expression of the anti-inflammatory macrophage marker CD163 will be assessed in adipose tissue samples using RT-PCR.

Inflammatory proteins found in adipose tissue measured using the Olink Target Inflammation Panel (includes 96 inflammation-associated proteins)Pre-exercise, immediately post-exercise, and 3 hours after exercise

The concentrations of 96 different inflammatory proteins (including various cytokines and adipokines) will be measured in adipose tissue lysates using the targeted inflammation Olink proximity extension assay panel. This assay measures all 96 proteins in a single assay and all are reported as normalized protein expression values.

Adipose tissue gene expression of monocyte chemoattractant protein-1 (MCP1) measured by PCR.Pre-exercise, immediately post-exercise, and 3 hours after exercise

Gene expression of the inflammatory cytokine MCP1 will be assessed in adipose tissue samples using RT-PCR.

Adipose tissue gene expression of leptin (LEPD) measured by PCR.Pre-exercise, immediately post-exercise, and 3 hours after exercise

Gene expression of the pro-inflammatory adipokine LEPD will be assessed in adipose tissue samples using RT-PCR.

Protein cargo of adipose extracellular vesicles measured using mass spectrometryPre-exercise, immediately post-exercise, and 3 hours after exercise

Adipose tissue samples will be cultured for 3 hours, and the culture media will be removed. From this media, extracellular vesicles will be isolated. In these extracellular vesicles, mass spectrometry will be performed to examine the entire proteome (all proteins) contained within these extracellular vesicles. Using the large number of proteins identified, the investigators will examine changes in categories of protein types (e.g., inflammatory proteins, metabolic proteins, transcriptional proteins).

Adipose Immune Cell PopulationsPre-exercise, immediately post-exercise, and 3 hours after exercise

The numbers of lymphocytes, monocytes, macrophages, and natural killer (NK) cells in the adipose tissue will be assessed by flow cytometry.

Adipose tissue gene expression of interleukin (IL)-6 measured by polymerase chain reaction (PCR).Pre-exercise, immediately post-exercise, and 3 hours after exercise

Gene expression of the inflammatory cytokine IL-6 will be measured in adipose tissue samples using real time (RT)-PCR.

Adipose tissue gene expression of inducible nitric oxide synthase (INOS) measured by PCR.Pre-exercise, immediately post-exercise, and 3 hours after exercise

Gene expression of the pro-inflammatory macrophage marker INOS will be assessed in adipose tissue samples using RT-PCR.

Adipose tissue gene expression of tumor necrosis factor alpha (TNFa) measured by PCR.Pre-exercise, immediately post-exercise, and 3 hours after exercise

Gene expression of the inflammatory cytokine TNFa will be assessed in adipose tissue samples using RT-PCR.

Adipose tissue gene expression of adiponectin (ADIPOQ) measured by PCR.Pre-exercise, immediately post-exercise, and 3 hours after exercise

Gene expression of the anti-inflammatory adipokine ADIPOQ will be assessed in adipose tissue samples using RT-PCR.

Adipose tissue gene expression of cluster of differentiation 68 (CD68) measured by PCR.Pre-exercise, immediately post-exercise, and 3 hours after exercise

Gene expression of the macrophage marker CD68 be assessed in adipose tissue samples using real time (RT)-PCR.

Adipose tissue gene expression of cluster of differentiation 206 (CD206) measured by PCR.Pre-exercise, immediately post-exercise, and 3 hours after exercise

Gene expression of the anti-inflammatory macrophage marker CD206 will be assessed in adipose tissue samples using RT-PCR.

Adipose tissue gene expression of adhesion G-protein coupled receptor E (ADGRE) measured by PCR.Pre-exercise, immediately post-exercise, and 3 hours after exercise

Gene expression of the macrophage marker ADGRE will be assessed in adipose tissue samples using RT-PCR.

Secondary Outcome Measures
NameTimeMethod
Adipocyte cell sizePre-exercise, immediately post-exercise, and 3 hours after exercise

Adipocyte cell size will be determined using methylene blue staining and microscopy.

Protein cargo of plasma extracellular vesicles measured using mass spectrometry extracellular vesiclesPre-exercise, immediately post-exercise, and 3 hours after exercise

Extracellular vesicles will be isolated from plasma samples. In these extracellular vesicles, mass spectrometry will be performed to examine the entire proteome (all proteins) contained within these extracellular vesicles. Using the large number of proteins identified, the investigators will examine changes in categories of protein types (e.g., inflammatory proteins, metabolic proteins, transcriptional proteins).

Plasma inflammatory cytokine concentrations measured using the Olink Target Inflammation Panel (includes 96 inflammation-associated proteins)Pre-exercise, immediately post-exercise, and 3 hours after exercise

The concentrations of 96 different inflammatory proteins (including various cytokines and adipokines) will be measured in plasma samples using the targeted inflammation Olink proximity extension assay panel. This assay measures all 96 proteins in a single assay and all are reported as normalized protein expression values.

Trial Locations

Locations (1)

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath